NYSE:INSP 9 December 2025 - 18 December 2025

Inspire Medical Systems, Inc., a leading developer of implantable devices to treat obstructive sleep apnea, is back in the spotlight. As of December 9, 2025, the stock is trading near the upper end of its recent rebound, supported by strong third-quarter results, favorable reimbursement changes, and a series of analyst upgrades—while simultaneously facing a fresh class-action investigation and lingering questions about growth and valuation. investors.inspiresleep.com+1